Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870840847376842752 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | PLOS ONE |
| description | |
| discipline_display | Open Access Journals |
| discipline_facet | Open Access Journals |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:103249 |
| institution | FRELIP |
| journal_source_facet | PLOS ONE |
| last_indexed | 2026-07-16T03:34:25.921Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis Open Access Journals General Open Access Journals |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Open Access Journals General Open Access Journals |
| subject_facet | Open Access Journals General Open Access Journals |
| title | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_alt | Corrección: Evaluación económica de atezolizumab en combinación con bevacizumab y quimioterapia para el cáncer cervical metastásico, persistente o recurrente en China: Un análisis de costo-efectividad Correction : Évaluation économique de l'atézolizumab en association avec le bévacizumab et la chimiothérapie pour le cancer du col de l'utérus métastatique, persistant ou récurrent en Chine : Une analyse coût-efficacité Correção: Avaliação econômica de atezolizumabe em combinação com bevacizumabe e quimioterapia para câncer cervical metastático, persistente ou recorrente na China: Uma análise de custo-efetividade |
| title_auth | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_es_txt | Corrección: Evaluación económica de atezolizumab en combinación con bevacizumab y quimioterapia para el cáncer cervical metastásico, persistente o recurrente en China: Un análisis de costo-efectividad |
| title_fr_txt | Correction : Évaluation économique de l'atézolizumab en association avec le bévacizumab et la chimiothérapie pour le cancer du col de l'utérus métastatique, persistant ou récurrent en Chine : Une analyse coût-efficacité |
| title_full | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_fullStr | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_full_unstemmed | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_pt_txt | Correção: Avaliação econômica de atezolizumabe em combinação com bevacizumabe e quimioterapia para câncer cervical metastático, persistente ou recorrente na China: Uma análise de custo-efetividade |
| title_short | Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis |
| title_sort | correction: economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in china: a cost-effectiveness analysis |
| topic | Open Access Journals General Open Access Journals |
| url | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0353864 |